ACM
IONS icon

Aster Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Aster Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Sell
190
-360
-65% -$27.1K ﹤0.01% 626
2026
Q1 		$16.6K Buy
550
+535
+3,567% +$42.2K 0.01% 572
2025
Q4 		$1.19K Buy
+15
New +$1.13K ﹤0.01% 999

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Aster Capital Management's IONS Position: Q2 2026 in Review

Aster Capital Management reduced its Ionis Pharmaceuticals (IONS) stake by 65% in Q2 2026, selling an estimated $27.1K and leaving 190 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Aster Capital Management first reported a position in IONS in Q4 2025 and has held it in 3 quarters since. The position peaked at $16.6K in Q1 2026. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Aster Capital Management held 190 shares of Ionis Pharmaceuticals worth $15.1K as of Q2 2026.
  • Aster Capital Management sold 360 Ionis Pharmaceuticals shares in Q2 2026, an estimated $27.1K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Aster Capital Management's portfolio in Q2 2026, its #626 holding.
  • Aster Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Aster Capital Management's Ionis Pharmaceuticals position peaked at $16.6K in Q1 2026.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.